MIRA INFORM REPORT

 

 

Report Date :

17.07.2012

 

IDENTIFICATION DETAILS

 

Name :

PINE PHARMA PRIVATE LIMITED

 

 

Registered Office :

D--91/2, Okhla Industrial Area, Phase—I, New Delhi – 110020

 

 

Country :

India

 

 

Financials (as on) :

31.03.2011

 

 

Date of Incorporation :

02.06.1987

 

 

Com. Reg. No.:

55-028161

 

 

Capital Investment / Paid-up Capital :

Rs.6.329 Millions

 

 

CIN No.:

[Company Identification No.]

U74899DL1987PTC028161

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

DELP04884F

DELP10122A

 

 

PAN No.:

[Permanent Account No.]

AAACP1693F

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturer and Exporter of Pharmaceutical Products.

 

 

No. of Employees :

30 (Approximately) (In Office + In Factory)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B (30)

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Maximum Credit Limit :

USD 30000

 

 

Status :

Moderate

 

 

Payment Behaviour :

Slow but correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having moderate track record. Profitability of the company appears to be low. However, trade relations are reported as fair. Business is active. Payments are reported to be slow but correct.

 

The company can be considered for business dealings with some caution. 

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – September 30, 2011

 

Country Name

Previous Rating

(30.06.2011)

Current Rating

(30.09.2011)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

 

 

 

 

 

 

 

 

 

 

 

 

INFORMATION PARTED BY

 

Name :

Mr. Manoj Tyagi

Designation :

Manager

Contact No.:

91-9910284340

Date :

11.07.2012

 

 

LOCATIONS

 

Registered Office / Factory :

D--91/2, Okhla Industrial Area, Phase—I, New Delhi – 110020, India

Tel. No.:

91-11-42701210 / 06 / 26810112 / 26810114 / 41611894

Mobile No.:

91-9810226622

91-9910284340 (Mr. Manoj Tyagi)

Fax No.:

91-11-41611894

E-Mail :

avafirm@gmail.com

info@pinepharma.com

pinepharma@hotmail.com 

Website :

www.pinepharma.com

 

 

DIRECTORS

 

As on 30.09.2011

 

Name :

Mr. Pawan Kumar Aggarwal

Designation :

Director

Address :

101 Kailash Hills, New Delhi, 110065, India

Date of Birth/Age :

 30.01.1951

Date of Appointment :

02.06.1987

DIN No.:

00720785

 

 

Name :

Mrs. Saroj Aggarwal

Designation :

Director

Address :

101 Kailash Hills, New Delhi, 110065, India

Date of Birth/Age :

11.08.1958

Date of Appointment :

02.06.1987

DIN No.:

00725691

 

 

Name :

Mr. Himanshu Aggarwal

Designation :

Director

Address :

101 Kailash Hills, New Delhi, 110065, India

Date of Birth/Age :

03.02.1977

Date of Appointment :

01.09.1998

DIN No.:

00725695

 

 

Name :

Mr. Pulkit Aggarwal

Designation :

Director

Address :

101 Kailash Hills, New Delhi, 110065, India

Date of Birth/Age :

11.04.1984

Date of Appointment :

01.03.2004

DIN No.:

01148369

 

 

KEY EXECUTIVES

 

Name :

Mr. Manoj Tyagi

Designation :

Manager

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on 30.09.2011

 

Names of Shareholders

 

No. of Shares

 

 

 

Pawan Kumar Aggarwal

 

18774

Saroj Aggarwal

 

11000

Himanshu Aggarwal

 

16000

Pulkit Aggarwal

 

16811

Prem Chand

 

150

Sabir Malik

 

150

Brijesh Aneja

 

100

D.N Tripathi

 

150

K.C Joshi

 

150

Total

 

63285

 

As on 30.09.2011

 

Equity Share Break up (Percentage of Total Equity)

 

Category

Percentage

Directors or relatives of Directors

100.00

 Total

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer and Exporter of Pharmaceutical Products.

 

 

Products :

·         Hemodialysis Fluid

·         Nephro-Clean (Dialyzer Reprocesser)

·         Hydrogen Peroxide

·         Sodium Hypochlorite

·         Formal Dehyde Solution

·         Critic Acid

·         Acetic Acid

·         Hemodialysis Solution

·         Bicarbonate Solution

·         Acetate Solution

·         Dialyzer Reprocessing Machine

·         Dialyzer

·         A.V. Blood Line / Tubing

·         Guide Wire

·         Fistula Needle

·         Double Lumen Catheter Kit

·         Femoral Vein Catheter

 

 

Exports :

 

Products :

·         Pharmaceutical Products

Countries :

·         Nepal

 

 

Imports :

 

Products :

·         Raw Material

Countries :

·         UK

·         USA

·         Japan

·         Taiwan

·         China

 

 

Terms :

 

Selling :

L/C

 

 

Purchasing :

L/C

 

 

GENERAL INFORMATION

 

Customers :

Wholesalers, Distributors and Manufacturers

 

 

No. of Employees :

30 (Approximately) (In Office + In Factory)

 

 

Bankers :

·         The Jammu and Kashmir Bank, First Floor, 9 LSC, Okhla Industrial Area Phase II, New Delhi – 110020, India

·         ICICI Bank

·         Axis Bank Limited

 

 

Facilities :

Secured Loan

As on

31.03.2011

(Rs. in

Millions)

As on

31.03.2010

(Rs. in

Millions)

 

 

 

Bank O/D

0.347

9.441

ICICI (Honda City)

0.000

0.000

Cholamandalam DBS Finance Limited

0.103

0.536

The Jammu and Kashmir Bank

0.000

0.000

Total

0.450

9.977

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

Tandon Brij and Company

Chartered Accountants

Address :

105-106, A.R.A Centre, Jhandewalan Extension, New Delhi – 110055, India

PAN.:

AACPT8125B

 

 

Sister Concern Company :

·         P. K. Scientific and Chemical

·         Akansha International

 

 

CAPITAL STRUCTURE

 

As on 31.03.2011

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

100000

Equity Shares

Rs.100/- each

Rs.10.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

63285

Equity Shares

Rs.100/- each

Rs.6.329 Millions

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2011

31.03.2010

31.03.2009

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

6.329

6.329

6.329

2] Share Application Money

0.000

0.000

0.000

3] Reserves & Surplus

1.243

0.831

0.808

4] (Accumulated Losses)

0.000

0.000

0.000

NETWORTH

7.572

7.160

7.137

LOAN FUNDS

 

 

 

1] Secured Loans

0.450

9.977

10.223

2] Unsecured Loans

0.000

0.000

0.000

TOTAL BORROWING

0.450

9.977

10.223

DEFERRED TAX LIABILITIES

0.000

0.000

0.000

 

 

 

 

TOTAL

8.022

17.137

17.360

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

3.724

4.058

4.549

Capital work-in-progress

0.000

0.000

0.000

 

 

 

 

INVESTMENT

0.000

0.000

0.000

DEFERREX TAX ASSETS

0.000

0.000

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

8.262

16.177

11.387

 

Sundry Debtors

3.431

3.777

4.489

 

Cash & Bank Balances

0.122

0.073

0.937

 

Other Current Assets

0.000

0.000

0.000

 

Loans & Advances

0.288

0.222

0.338

Total Current Assets

12.103

20.249

17.151

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Sundry Creditors

4.113

4.579

3.698

 

Other Current Liabilities

3.692

2.591

0.642

 

Provisions

0.000

0.000

0.000

Total Current Liabilities

7.805

7.170

4.340

Net Current Assets

4.298

13.079

12.811

 

 

 

 

MISCELLANEOUS EXPENSES

0.000

0.000

0.000

 

 

 

 

TOTAL

8.022

17.137

17.360

 


PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2011

31.03.2010

31.03.2009

 

SALES

 

 

 

 

 

Income

34.179

25.059

23.917

 

 

Other Income

NA

4.792

0.555

 

 

TOTAL                                    

NA

29.851

24.472

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Office Expenses

NA

29.743

25.501

 

 

Administrative Expenses

 

 

 

 

 

Advertising Expenses

 

 

 

 

 

TOTAL                                    

NA

29.743

25.501

 

 

 

 

 

 

PROFIT BEFORE TAX

0.439

0.108

(1.029)

 

 

 

 

 

Less

TAX                                                                 

NA

0.000

0.000

 

 

 

 

 

 

PROFIT AFTER TAX

NA

0.108

(1.029)

 

 

 

 

 

 

Earnings Per Share (Rs.)

NA

1.08

NA

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2011

31.03.2010

31.03.2009

PAT / Total Income

(%)

NA

0.36

(4.20)

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

1.28

0.43

(4.30)

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

2.77

0.44

(4.74)

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.06

0.02

(0.14)

 

 

 

 

 

Debt Equity Ratio

(Total Liability/Networth)

 

1.09

2.39

2.04

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.55

2.82

3.95

 

 

LOCAL AGENCY FURTHER INFORMATION

 

 

Check List by Info Agents

Available in Report (Yes / No)

1) Year of Establishment

 Yes

2) Locality of the firm

 Yes

3) Constitutions of the firm

 Yes

4) Premises details

No

5) Type of Business

 Yes

6) Line of Business•

 Yes

7) Promoter’s background

 Yes

8) No. of employees

 Yes

9) Name of person contacted

 Yes

10) Designation of contact person

 Yes

11) Turnover of firm for last three years

 Yes

12) Profitability for last three years

 Yes

13) Reasons for variation <> 20%

--

14) Estimation for coming financial year

No

15) Capital in the business

 Yes

16) Details of sister concerns

 Yes

17) Major suppliers

No

18) Major customers

No

19) Payments terms

 Yes

20) Export / Import details (if applicable)

 Yes

21) Market information

--

22) Litigations that the firm / promoter

--

23) Banking Details

 Yes

24) Banking facility details

 Yes

25) Conduct of the banking account

--

26) Buyer visit details

--

27) Financials, if provided

 Yes

28) Incorporation details, if applicable

 Yes

29) Last accounts filed at ROC

 Yes

30) Major Shareholders, if available

 Yes

 

FINANCIAL RESULTS:

 

During the year, the company has improved the working and the sales are Rs.34.179 Millions as compared to Rs.25.059 Millions the previous year. During the year the company has a net profit of Rs.0.439 Million.

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                              None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.54.92

UK Pound

1

Rs.85.47

Euro

1

Rs.67.15

 

INFORMATION DETAILS

 

Information Gathered by :

SBA

 

 

Report Prepared by :

BSN


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

3

PAID-UP CAPITAL

1~10

3

OPERATING SCALE

1~10

4

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

4

--PROFITABILIRY

1~10

3

--LIQUIDITY

1~10

3

--LEVERAGE

1~10

3

--RESERVES

1~10

4

--CREDIT LINES

1~10

3

--MARGINS

-5~5

-

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

30

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

-

NB

                                       New Business

-

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.